Times of marketing and distributing tobacco products cleverly designed to increase addiction and consumption among children and teenagers is over. The tobacco industry’s attempts at new products to increase addiction, thinly veiled as existing products are finally getting some controls. That is the message the FDA sent the tobacco industry on Sept 15th when it halted further sale and distribution of four R.J. Reynolds cigarette products.
The products failed to meet the standards for protecting public health under the Federal Food, Drug & Cosmetic Act. The banned products, especially appealing to youth were removed because they contained new ways of delivering menthol, higher levels of menthol (which can make the experience of smoking more pleasurable because it is cooling and smoother), the addition of sugars/sweeteners, and other changes that increase harmful chemical constituents.
We don’t fully understand the path that leads youth to begin using tobacco, but we know that nine out of 10 adult smokers in Ohio began smoking before age 18. Ohio State University is home to one of the 14 tobacco research centers funded by the National Institutes of Health (NIH) and the FDA to conduct research aimed at understanding tobacco-use patterns and the factors that make someone more likely to use tobacco. The goal is twofold: to put science behind the FDA’s regulation of the tobacco industry and to develop public-health interventions to reduce tobacco use and, therefore, the associated health burdens. The FDA has been slow to act since the inception of its authority, and it is finally using its teeth. View full article
View FDA issues orders that will stop further U.S. sale and distribution of four R.J. Reynolds Tobacco Company cigarette products
Dr. Peter Shields (26 September 2015) FDA finally employs its hammer on Big Tobacco [online newspaper]. Retrieved from http://ow.ly/SHa1A